Ginkgo Bioworks raises $45M

What does Gingko Bioworks do?

Ginkgo Bioworks, is an organism design company with a mission to make bilogy easier to engineer. The company has built world’s first organism engineering foundry in a 11,000 square foot facility in Boston and has a great team using the foundry for bringing new organisms to customers. The company is engineering naturally. They are expanding the role of biology in our world.  The biodiversity of our nature holds answers to challenges in energy, health, materials, food and plenty of other things. Ginkgo’s organism engineers learn from nature for developing new organisms which replace technology with biology.

How much Ginkgo Bioworks was funded?

Ginkgo Bioworks raised  $45M in Series B funding on July 23, 2015 from Viking Global Investors (Lead), OS Fund and Felicis Ventures

Previous funding

$120k in Seed round on July 16, 2014 from China Rock Capital, Farzad (Zod) Nazem, David Spector, Y Combinator and TEEC Angel Fund Partners: Biao He, Eugene Zhang, and Jinlin Wang.

$9M in Series A funding on March 18, 2015 from Data Collective, iGlobe Partners, Vast Ventures, Felicis Ventures and OS Fund

What is next for Ginkgo Bioworks?

The organism design company will use the latest funding raised for expanding into new categories such as cosmetics, pharmaceuticals, nutrition, health and probiotics and for hiring additional engineers and designers to its world class team and for building out Bioworks 2, the next generation of the company’s robotic foundry.

More about Ginkgo Bioworks

Ginkgo Bioworks was founded in 2008 by Reshma Shetty and Jason Kelly. It has its headquarters in Boston, MA. It is an organism design company which is building organisms to spec for consumers across markets which include consumer goods, health and food.  Its organism engineers work with customers directly for designing microbes for their specific needs. The company currently has more than 20 organism design contracts with customers like Fortune 500 companies.